EXC

Essex Angel Capital Inc. (TSX VENTURE: EXC) (the "Corporation" or "Essex") is pleased to announce that FlagshipSailsRX, LLC ("Flagship") has signed on as the sales partner for Wellness Indicators Inc. ("Wellness Indicators"), one of the companies in the Essex portfolio. Flagship will be assisting Wellness Indicators, based in Waukonda, Illinois, in launching a new industry-first preclinical wellness assessment tool called Health Equater™ Assessment Profile that will be marketed to insurance companies and large employers. Having recently completed a successful field trial with a large North American insurance company, Wellness Indicators expects to introduce the test commercially in the first quarter of 2012.

"We are delighted that Wellness Indicators has taken on such astute sales partners as FlagshipSailsRX," said Rick Galdi, CEO & President of Essex Angel Capital. "They work with exactly the right market segments and clients, and most of their staff has 20+ years of experience in healthcare sales. This partnership is independent verification that Wellness Indicators has a product that is ready for a successful launch."

Flagship is a healthcare sales outsourcing company founded in 2010, which offers to early-stage companies the platform, resources, connections, and tools of Fortune 50 companies. "Our value proposition is speed to market, because they're hiring a whole team instead of one person for basically the same money," said Flagship Partner and co-founder Jeff Zavada. "We bring them the tools and technologies and sales operational systems, and they just tap into an existing model versus having to build it on their own. We've got literally thousands of relationships we can call on immediately. And all of us at Flagship believe that this test from Wellness Indicators is a true game-changer." Zavada previously worked for United Healthcare Services Inc. as vice president of sales and as the chief sales officer for pharmacy services at Walgreens Co.

Flagship's Advisory Board contains a mix of entrepreneurs and people experienced in working for Fortune 50 companies, including Stan Blaylock of Walgreens Health Services, Amy Knapp of United Healthcare Services Inc. and Aetna Inc., Dr. Bill McGuire of UnitedHealth Group Inc. and Ken Fasola of HealthMarkets Inc.

About Essex Angel Capital

Essex Angel Capital of Windsor, Ontario, is a publicly traded company engaged in the business of debt and equity investment in privately held early-stage companies. Essex is traded on the TSX Venture Exchange under the symbol "EXC."

About Wellness Indicators Inc.

Wellness Indicators is part of the investment portfolio of Essex Angel Capital. Wellness Indicators is the developer of a first-to-market new wellness assessment test scheduled for commercial launch in the first quarter of 2012. The Health Equater Assessment Profile is a unique inexpensive urine test that screens for a number of biomarkers indicating levels of wellness; results are available in approximately five minutes. The Health Equater has the potential to fill an enormous unmet need in the wellness industry for a cost-effective easy-to-use portable screening tool.

This press release contains certain forward-looking statements about the future plans and intentions of companies in the Corporation's portfolio. Wherever possible, words such as "may," "will," "should," "could," "expect," "plan," "intend," "anticipate," "believe," "estimate," "predict," or "potential," or the negative or other variations of these words, or similar words or phrases, have been used to identify these forward-looking statements. These statements reflect Management's current beliefs and are based on information currently available to Management as at the date hereof. Forward-looking statements included or incorporated by reference in this press release include statements with respect to future business activity of Wellness Indicators.

Forward-looking statements involve significant risk, uncertainties, and assumptions. Many factors could cause actual results, performance, or achievements to differ materially from the results discussed or implied in the forward-looking statements. These factors should be considered carefully and readers should not place undue reliance on the forward-looking statements. Although the forward-looking statements contained in this press release are based upon what management believes to be reasonable assumptions, the Corporation cannot assure readers that actual results will be consistent with these forward-looking statements. These forward-looking statements are made as of the date of this press release, and the Corporation assumes no obligation to update or revise them to reflect new events or circumstances, except as required by law.

Neither TSX-V nor its Regulation Services Provider (as that term is defined in the policies of the TSX-V) accepts responsibility for the adequacy or accuracy of this release.

Contacts: Essex Angel Capital Inc. Richard Galdi Chief Executive Officer 519-969-0129 rgaldi@essexangelcapital.com www.essexangelcapital.com FlagshipSailsRX Jeff Zavada Partner 262-696-3676 jzavada@fssrx.com www.flagshipsailsrx.com